enVVeno Medical Corporation (NVNO)
Track the next or latest earnings date for enVVeno Medical Corporation, review consensus estimates, and see cached AI analysis for recent quarterly results.
Recent earnings news
stocktitan.net · 1 day ago
Novo Nordisk reports progress on its DKK 15B, 12‑month share repurchase, with 23.0M B shares bought for DKK 6.22B and 0.9% held in treasury.
Navitas Semiconductor Q2 2026 results call set for July 27 | NVTS Stock Newswww.stocktitan.net · 12 hours ago
CEO Chris Allexandre and CFO Tonya Stevens will host a 2 p.m. PT call to discuss Q2 2026 results and business outlook after the market close.
Nvidia’s New Way to Profit From the AI Boom: Will Startups Pay Up?mitrade.com · 1 day ago
Nvidia (NVDA) will let AI startups use its chips now and pay with a share of future revenue.The company detailed the revenue-sharing program in a July 1 blog post. The move casts Nvidia as a financier
Novo Nordisk (NYSE: NVO) Stock Price Could Be Trading At A 48% Discount As Medicare Expands GLP-1 Coverageforeignpolicyjournal.com · 3 days ago
The Foreign Policy Journal is a leading news publication covering US and international politics, business, and global affairs news.
Novo Nordisk: Stock Price Is Only Beginning To Catch Up With Business Fundamentals (NVO) | Seeking Alphaseekingalpha.com · 3 days ago
Novo Nordisk (NVO) rated Buy as oral Wegovy lifts GLP-1 sales, expands obesity market and boosts 2026 guidance.
Latest earnings date
Time not specified
Fiscal quarter: 2025-12-31
EPS estimate: N/A
Revenue estimate: N/A
Market cap: $7.55M
Analysis snapshot
No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.
Recent earnings history
Browse the calendar week| Date | Quarter | Report window | EPS est. | Revenue est. |
|---|---|---|---|---|
| Mar 19, 2026 | 2025-12-31 | Time not specified | N/A | N/A |
| Feb 26, 2026 | 2025-12-31 | Time not specified | N/A | N/A |